down arrow

IO Biotech, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4497781090
USD
0.68
0.05 (7.21%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.660.72

52 Week

0.322.79
Valuation
Technical
Day's Volume

CASH

1.02 M

Shareholding (Mar 2025)

FII

8.54%

Held by 7 FIIs

DII

69.52%

Held by 4 DIIs

Promoter

21.30%

How big is IO Biotech, Inc.?

22-Jun-2025

As of Jun 18, IO Biotech, Inc. has a market capitalization of 86.96 million, with net sales of 0.00 million and a net profit of -98.46 million over the latest four quarters. Shareholder's funds are at 47.02 million, and total assets are 67.70 million as of Dec 24.

As of Jun 18, IO Biotech, Inc. has a market capitalization of 86.96 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of Net Sales for the latest four quarters is 0.00 million, while the sum of Net Profit for the same period is -98.46 million.<BR><BR>As of Dec 24, the reporting period shows Shareholder's Funds at 47.02 million and Total Assets at 67.70 million.

Read More

What does IO Biotech, Inc. do?

22-Jun-2025

IO Biotech, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $22 million and a market cap of $86.96 million. The company has no dividend yield and negative financial metrics, including a debt equity ratio of -1.38 and a return on equity of -372.63%.

Overview: <BR>IO Biotech, Inc. operates in the Pharmaceuticals & Biotechnology industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: -22 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 86.96 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -1.38 <BR>Return on Equity: -372.63% <BR>Price to Book: 3.29<BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

Read More

Is IO Biotech, Inc. technically bullish or bearish?

20-Sep-2025

As of September 12, 2025, IO Biotech, Inc. has shifted to a bullish trend, supported by a mildly bullish daily moving average and a bullish monthly Bollinger Band, despite mixed signals from the weekly MACD and KST, while underperforming the S&P 500 recently but significantly outperforming year-to-date and over the past year.

As of 12 September 2025, the technical trend for IO Biotech, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a mildly bullish daily moving average and a bullish monthly Bollinger Band. However, the weekly MACD remains mildly bearish, indicating some mixed signals. The KST is bullish on a weekly basis but bearish monthly, and the OBV shows a mildly bullish trend weekly with no trend monthly. <BR><BR>In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -15.18% and -22.49% respectively, while it has outperformed significantly year-to-date and over the past year, with returns of 76.09% and 39.66%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 119 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-12.97

stock-summary
Return on Equity

-6,369.28%

stock-summary
Price to Book

74.49

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-26 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-61.25%
0%
-61.25%
6 Months
-55.09%
0%
-55.09%
1 Year
-21.17%
0%
-21.17%
2 Years
-43.96%
0%
-43.96%
3 Years
-77.01%
0%
-77.01%
4 Years
-93.78%
0%
-93.78%
5 Years
0%
0%
0.0%

IO Biotech, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is IO Biotech, Inc. technically bullish or bearish?

As of 12 September 2025, the technical trend for IO Biotech, Inc. has changed from mildly bullish to bullish. The current stance is bullish, supported by a mildly bullish daily moving average and a bullish monthly Bollinger Band. However, the weekly MACD remains mildly bearish, indicating some mixed signals. The KST is bullish on a weekly basis but bearish monthly, and the OBV shows a mildly bullish trend weekly with no trend monthly. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of -15.18% and -22.49% respectively, while it has outperformed significantly year-to-date and over the past year, with returns of 76.09% and 39.66%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-350.28%
EBIT to Interest (avg)
-82.32
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.38
Sales to Capital Employed (avg)
0
Tax Ratio
1.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
49.22%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.99
EV to EBIT
-0.71
EV to EBITDA
-0.71
EV to Capital Employed
-6.96
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-372.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 3 Schemes (0.64%)

Foreign Institutions

Held by 7 Foreign Institutions (8.54%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is -26.57% vs 2.36% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-22.90",
          "val2": "-21.30",
          "chgp": "-7.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.30",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.60",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-26.20",
          "val2": "-20.70",
          "chgp": "-26.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -10.92% vs -20.42% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-94.30",
          "val2": "-90.70",
          "chgp": "-3.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-95.50",
          "val2": "-86.10",
          "chgp": "-10.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-22.90
-21.30
-7.51%
Interest
0.30
0.00
Exceptional Items
-2.60
0.00
Consolidate Net Profit
-26.20
-20.70
-26.57%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is -26.57% vs 2.36% in Jun 2024

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-94.30
-90.70
-3.97%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-95.50
-86.10
-10.92%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -10.92% vs -20.42% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About IO Biotech, Inc. stock-summary
stock-summary
IO Biotech, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."